← Back to Clinical Trials
Recruiting NCT07275528

NCT07275528 Effects of Task Oriented Circuit Training on Functional Mobility and Activity Participation in Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07275528
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-09-13
Primary Completion 2025-12-10

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
ExperimentalCONVENTIONAL PHYSICAL THERAPY

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2025-09-13 with a primary completion date of 2025-12-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

cerebral palsy hemiplegia often experiences motor problems that primarily affect one side of their body. Children with hemiplegia have difficulties in functional activities. Task-Oriented Circuit Training (TOCT) is a high-intensity, progressive intervention designed to improve functional motor skills by engaging individuals in repetitive, task-specific exercis it is randomized control trail conducted with 34 patients included according to inclusion and exclusion criteria. Functional mobility assessed through 6-minute walk test and activity participation evaluated through Child Engagement in Daily Life measurement scale.

Eligibility Criteria

Inclusion Criteria: * Diagnosed cases of hemiplegic cerebral palsy * Both genders are included * The children were between 5 and 12 years old. * Their motor function was at a level I or II based on the GMFCS, * The degree of spasticity grade 1 to 2 based on the Modified Ashworth Scale. Exclusion Criteria: * Visual or hearing loss * Cognitive impairment * Seizures * A botulinum toxin injection in the previous six months, * Lower extremity surgery * Musculoskeletal disorders * Structural deformities in the spine and/or lower limbs.

Contact & Investigator

Central Contact

Ahyab Mehreen, DPT

✉ ahyab.mehreen@gmail.com

📞 +92 3349279563

Frequently Asked Questions

Who can join the NCT07275528 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 12 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07275528 currently recruiting?

Yes, NCT07275528 is actively recruiting participants. Contact the research team at ahyab.mehreen@gmail.com for enrollment information.

Where is the NCT07275528 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07275528 clinical trial?

NCT07275528 is sponsored by Foundation University Islamabad. The trial plans to enroll 34 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology